Prelude Capital Management, LLC Harrow Health, Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 26,958 shares of HROW stock, worth $911,989. This represents 0.08% of its overall portfolio holdings.

Number of Shares

26,958

Previous 26,958 -0.0%

Holding current value

$911,989

Previous $1.21 Million -0.0%

% of portfolio

0.08%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.85 - $46.47 $1.63 Million - $3.64 Million	-78,251 Reduced 74.38%	26,958 $1.21 Million
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $49,500 - $107,118	-4,950 Reduced 4.49%	105,209 $2.2 Million
Q1 2024 May 15, 2024	BUY	$9.3 - $13.23 $161,913 - $230,334	17,410 Added 18.77%	110,159 $1.46 Million
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $24,364 - $49,210	3,008 Added 3.35%	92,749 $1.04 Million
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $607,288 - $955,732	43,285 Added 93.17%	89,741 $1.29 Million
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $47,819 - $77,304	2,753 Added 6.3%	46,456 $884,000
Q1 2023 May 15, 2023	SELL	$13.84 - $21.46 $833,389 - $1.29 Million	-60,216 Reduced 57.95%	43,703 $924,000
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $193,551 - $278,277	18,828 Added 22.13%	103,919 $1.53 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $83,622 - $316,672	-12,728 Reduced 13.01%	85,091 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $16,721 - $22,507	2,908 Added 3.06%	97,819 $712,000
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $164,463 - $210,377	24,293 Added 34.4%	94,911 $647,000
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $71,578 - $101,052	8,421 Added 13.54%	70,618 $610,000
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $59,268 - $89,877	8,479 Added 15.78%	62,197 $565,000
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $139,404 - $231,019	20,869 Added 63.53%	53,718 $499,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $773,848 - $1.36 Million	-123,618 Reduced 79.01%	32,849 $222,000
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $12,490 - $18,184	2,624 Added 1.71%	156,467 $1.07 Million
Q3 2020 Nov 16, 2020	SELL	$4.71 - $7.36 $197,975 - $309,362	-42,033 Reduced 21.46%	153,843 $860,000
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $394,836 - $707,643	-109,373 Reduced 35.83%	195,876 $1.02 Million
Q1 2020 May 15, 2020	BUY	$3.5 - $7.31 $543,599 - $1.14 Million	155,314 Added 103.59%	305,249 $1.17 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $7.88 $323,844 - $554,759	-70,401 Reduced 31.95%	149,935 $1.17 Million
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $489,665 - $801,088	100,136 Added 83.31%	220,336 $1.24 Million
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $198,227 - $410,613	-47,197 Reduced 28.19%	120,200 $1.05 Million
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $795,135 - $1.19 Million	167,397 New	167,397 $834,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $916M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Harrow Health, Inc. Transaction History